latrepirdine has been researched along with Disease Exacerbation in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachurin, SO; Buchman, VL; Chaprov, K; Deykin, AV; Funikov, S; Ivanova, TA; Kukharsky, MS; Lysikova, EA; Ninkina, N; Rezvykh, A; Yu Aksinenko, A | 1 |
| Coughlan, KS; Hogg, MC; Mitchem, MR; Prehn, JH | 1 |
| Gravitz, L | 1 |
| Afanasieva, MA; Alentov, II; Bachurin, SO; Buchman, VL; Khritankova, I; Ninkina, NN; Peters, O; Shelkovnikova, TA; Tarasova, TV; Ustyugov, AA | 1 |
4 other study(ies) available for latrepirdine and Disease Exacerbation
| Article | Year |
|---|---|
A bioisostere of Dimebon/Latrepirdine delays the onset and slows the progression of pathology in FUS transgenic mice.
Topics: Amyotrophic Lateral Sclerosis; Animals; Disease Progression; Gait; Humans; Indoles; Mice; Mice, Transgenic; RNA-Binding Protein FUS | 2021 |
"Preconditioning" with latrepirdine, an adenosine 5'-monophosphate-activated protein kinase activator, delays amyotrophic lateral sclerosis progression in SOD1(G93A) mice.
Topics: AMP-Activated Protein Kinases; Amyotrophic Lateral Sclerosis; Animals; Cell Survival; Cells, Cultured; Disease Progression; Energy Metabolism; Enzyme Activation; Female; Indoles; Injections, Intraperitoneal; Male; Mice, Inbred C57BL; Mice, Transgenic; Motor Neurons; Mutation; Risk; Spinal Cord; Superoxide Dismutase; Superoxide Dismutase-1 | 2015 |
Drugs: a tangled web of targets.
Topics: Alanine; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azepines; Clinical Trials as Topic; Disease Progression; Genetic Therapy; Glycogen Synthase Kinase 3; Humans; Indoles; Memantine; Methylene Blue; Molecular Targeted Therapy; Nerve Growth Factor; Neurofibrillary Tangles; Phosphorylation; tau Proteins | 2011 |
Dimebon slows progression of proteinopathy in γ-synuclein transgenic mice.
Topics: Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Disease Progression; gamma-Synuclein; Indoles; Male; Mice; Mice, Transgenic; Motor Neurons; Neuroprotective Agents; Rotarod Performance Test; Spinal Cord | 2012 |